يعرض 1 - 20 نتائج من 65 نتيجة بحث عن '"Ashok, Panneerselvam"', وقت الاستعلام: 0.59s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Institut Català de la Salut, [Agarwal N] Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, USA. [Azad A] Peter MacCallum Cancer Centre & Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. [Carles J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Chowdhury S] Guy’s, King’s & St. Thomas’ Hospitals, & Sarah Cannon Research Institute, London, UK. [McGregor B] Lank Center of Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. [Merseburger AS] Department of Urology, University Hospital Schleswig-Holstein, Lubeck, Germany, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  3. 3
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    المصدر: European journal of cancer, 49 (12

    وصف الملف: 1 full-text file(s): application/pdf

  19. 19

    المساهمون: Medical oncology, CCA - Innovative therapy

    المصدر: van den Eertwegh, A J, Karakiewicz, P, Bavbek, S, Rha, S Y, Bracarda, S, Bahl, A, Ou, Y C, Kim, D, Panneerselvam, A, Anak, O & Grunwald, V 2013, ' Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program ', Urology, vol. 81, no. 1, pp. 143-149 . https://doi.org/10.1016/j.urology.2012.09.019
    Urology, 81(1), 143-149. Elsevier Inc.

  20. 20